Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment.
D000328:Adult; D000368:Aged; D000818:Animals; D001772:Blood Cell Count; D001792:Blood Platelets; D001803:Blood Transfusion; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006400:Hematocrit; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007279:Injections, Subcutaneous; D007501:Iron / Q000378:metabolism; D007504:Iron Radioisotopes; D007951:Leukemia, Myeloid / Q000097:blood; D007958:Leukocyte Count; D007964:Leukocytosis / Q000097:blood; D008297:Male; D051379:Mice; D008875:Middle Aged; D011087:Polycythemia Vera / Q000097:blood*; D055728:Primary Myelofibrosis / Q000097:blood*
D007504:Iron Radioisotopes; D004921:Erythropoietin; D007501:Iron